News Merrimack goes back to drawing board with $1bn Ipsen sell-of... Merrimack sells off Onivyde and generic cancer drug
News Shire's Onivyde pancreatic cancer drug approved in EU Drug approved in metastatic adenocarcinoma of the pancreas.
News Sanofi to buy UK vaccines developer Vicebio for $1.6bn Sanofi has agreed to buy UK startup Vicebio, which was formed to produce improved, more potent shots that are simpler to manufacture, for $1.6bn.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face